Clara Biotech hits $850K in seed funding roundup, preparing to launch first product
June 15, 2021 | Startland News Staff
An emerging biotech startup in the region is reporting a busy spring with a significant seed round already raised and key steps under way to launch its product: a solution that removes manufacturing roadblocks for breakthrough drugs.
“We’re in an exciting and growing space and currently have low regulatory hurdles in the research stage,” said Jim West, co-founder of Clara Biotech, a Lawrence-based company already buoyed by its founding team’s expertise in exosome technologies, pharmaceutical development, engineering and building life science companies.
Elevator pitch: Clara Biotech is building an exosome isolation platform that solves a huge roadblock around manufacturing that helps the entire biopharma industry make future breakthrough drugs that may not otherwise get approved. We founded Clara Biotech to help move exosomes from research to patient.
Jim West, Clara Biotech
“We’re looking for smart money investors who can help us develop our market position, scale the technology and become the platform that companies can use to get exosome therapies to the patients who need them most,” he continued, detailing Clara Biotech’s momentum in a company snapshot update.
Off the heels of announcing an undisclosed investment by Kansas City-based Fountain Innovation Fund, the startup has raised $850,000 for its seed round, West said, with additional investments from angel investors in Boston, San Francisco, India and Kansas City.
Dr. Mei He, Clara Biotech
Clara Biotech recently received a tranche of angel tax credits, still available to qualified investors, he added.
The seed round is expected to help the company debut its beta ExoRelease exosome isolation kit, as well as continue to scale, West said.
Click here to read Clara Biotech’s full snapshot update.
“We are generating revenue and launching our first product,” he said. “At a recent conference for exosome therapeutics, sample preparation quality was the major limiting factor in manufacturing and receiving FDA approval. Our groundbreaking solution resulted in a 70 percent lead conversion rate of all companies attending (which includes investment groups and competitors). We’re currently working with and growing a number of paying early customers including some major pharmaceutical players.”
Founded in 2018 at the Bioscience and Technology Business Center in Lawrence, Clara Biotech’s therapeutic applications range from personalized medicine, targeted drug delivery, immunotherapy, and orphan and rare diseases. It’s solutions are focused on early cancer detection, Alzheimer’s disease, and virus detection.
Click here to learn more about Clara Biotech and how its technology works.
This story is possible thanks to support from the Ewing Marion Kauffman Foundation, a private, nonpartisan foundation that seeks to build inclusive prosperity through a prepared workforce and entrepreneur-focused economic development. The Foundation works to change conditions, address root causes, and break down systemic barriers so that all people – regardless of race, gender, or geography – have the opportunity to achieve economic stability, mobility, and prosperity.
For more information, visit www.kauffman.org and connect with us at www.twitter.com/kauffmanfdn and www.facebook.com/kauffmanfdn.
2021 Startups to Watch
stats here
Related Posts on Startland News
PHKC awards $25K to Alchemy Sandbox winners; It’s amazing when someone understands your vision, founder says
Year one challenges can be difficult for entrepreneurs to swallow, James Thomas noted, but he’s raising a cup to the first anniversary of Brain Freeze Mobile Daiquiri Shop with validation and a splash of funding. Two days after completing The Porter House KC’s fourth small business development cohort and competing in its finale competition, Thomas…
After his eye-catching KCI installation took flight, Willie Cole had 100+ horns leftover; He kept building
Willie Cole didn’t choose to be an artist. It’s always been part of him. “I think I was an artist in a previous life,” said the contemporary American sculptor, printer and perceptual engineer. “When I was 3 years old, my mom found me drawing in the kitchen, and since then, my family always said I…
Lawrence cybersecurity startup raises $1.85M pre-seed round led by KC’s Flyover Capital
A startup focused on detecting hidden malware and preventing costly ransomware attacks announced a power-packed pre-seed funding round to push its pending launch — with the backing of a trio of high-profile regional investors. The investment in cybersecurity pioneer Invary was led by Flyover Capital, with additional participation from NetWork Kansas GROWKS Equity program, and…
Pickle and Suede: Sporty new line plays on jewelry brand’s versatility, flexes creative muscle
Nickel and Suede is hitting the court this summer, served co-founder Kilee Nickels. The Liberty-based jewelry brand — which just celebrated its ninth birthday — has released a pickleball paddle in collaboration with Recess Pickleball, along with a line of “just the right” accessories to coordinate. “It’s kind of our stamp of approval,” Nickels said.…